Home Qualitative detection of the Marburg I alloenzyme of factor VII-activating protease by an immunoassay and its comparison to PCR testing
Article
Licensed
Unlicensed Requires Authentication

Qualitative detection of the Marburg I alloenzyme of factor VII-activating protease by an immunoassay and its comparison to PCR testing

  • Herbert Schwarz , Sina Stephan , Johannes J. Sidelmann , Bodo Fischer , Harald Althaus , Martin Hahn , Andreas Kappel , Matthias Ehm and Frank Vitzthum
Published/Copyright: September 10, 2010

Abstract

Background: The Marburg I (MRI) single nucleotide poly-morphism (SNP) of the factor VII-activating protease (FSAP) gene has been associated with thrombophilia, thromboembolism, atherosclerosis, and the incidence and progression of carotid stenosis. At present, MRI SNP testing is mainly performed using costly nucleic acid analysis. The ratio between FSAP activity and antigen concentrations in citrated plasma has been used to assess the FSAP genotype.

Methods: This article describes the development of a prototype ELISA for the detection of the MRI FSAP alloenzyme, and its correlation to FSAP genotypes to assess whether a positive MRI FSAP ELISA result may be used as a surrogate marker for the presence of the MRI SNP.

Results: ELISA results were correlated with FSAP genotypes from 523 blood donors measured using PCR. Diagnostic sensitivity and specificity of the assay for determina-tion of the genotype were 100% (95% confidence interval [CI]: 93.36–100) and 99.79% (95% CI: 98.80–99.96), respectively. Maximum run-to-run, within-run, and total coefficients of variation were 7.8%, 7.9%, and 9.9%, respectively. No cross-reactivities with homologues of the MRI FSAP alloenzyme were observed. Test performance was not affected by typical interfering compounds.

Conclusions: The data demonstrate that an immunoassay applying antibodies specific to the MRI FSAP alloenzyme can provide sufficiently accurate detection of the MRI SNP. This will significantly simplify MRI FSAP testing, particularly in large cohorts.

Clin Chem Lab Med 2010;48:1745–9.


Corresponding author: Frank Vitzthum, Siemens Healthcare Diagnostics Products GmbH, Pre-Development, Emil-von-Behring-Str. 76, D-35001 Marburg, Germany Fax: +49 6421 39 3144,

Received: 2010-4-23
Accepted: 2010-6-3
Published Online: 2010-09-10
Published in Print: 2010-12-01

©2010 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Editorial
  2. Biomarkers of cardiovascular risk – matters of prediction and precision
  3. Reviews
  4. Inflammatory markers, cholesterol and statins: pathophysiological role and clinical importance
  5. C-reactive protein and venous thromboembolism: causal or casual association?
  6. Perspectives
  7. Statistical methods for assessment of added usefulness of new biomarkers
  8. Genetics and Molecular Diagnostics
  9. ThalassoChip, an array mutation and single nucleotide polymorphism detection tool for the diagnosis of β-thalassaemia
  10. General Clinical Chemistry and Laboratory Medicine
  11. Glycated hemoglobin vs. the oral glucose tolerance test for the exclusion of impaired glucose tolerance in high-risk individuals
  12. Impact of glucuronide interferences on therapeutic drug monitoring of posaconazole by tandem mass spectrometry
  13. Evaluation of D-dimer in the diagnosis of suspected aortic dissection
  14. Quantification of coagulation factor XIII activity by a thio-NADH based assay using factor XIII immuno-depleted plasma as a diluent for calibration
  15. Qualitative detection of the Marburg I alloenzyme of factor VII-activating protease by an immunoassay and its comparison to PCR testing
  16. Fatty acid composition of serum phospholipids in cystic fibrosis (CF) patients with or without CF related liver disease
  17. Development and validation of a combined method for the biomonitoring of omega-3/-6 fatty acids and conjugated linoleic acids in different matrices from human and nutritional sources
  18. Evaluation of the Sysmex UF-1000i® urine flow cytometer in the diagnostic work-up of suspected urinary tract infection in a Dutch general hospital
  19. Association between coffee consumption and the estimated glomerular filtration rate in the general Japanese population: preliminary data regarding C-reactive protein concentrations
  20. Lactic acid is of low predictive value for the diagnosis of bacterial infection in ventricular cerebrospinal fluid samples containing residual blood
  21. Accuracy of the Precision® point-of-care ketone test examined by liquid chromatography tandem-mass spectrometry (LC-MS/MS) in the same fingerstick sample
  22. Cancer Diagnostics
  23. Combination of polymorphisms within the HDAC1 and HDAC3 gene predict tumor recurrence in hepatocellular carcinoma patients that have undergone transplant therapy
  24. Global DNA methylation: comparison of enzymatic- and non-enzymatic-based methods
  25. Determination of biological variation of α-fetoprotein and choriogonadotropin (β chain) in disease-free patients with testicular cancer
  26. Infectious Diseases
  27. Investigation of the relationship between apolipoprotein E gene polymorphisms and hepatitis B virus infection in northern China
  28. Helicobacter pylori infection and the severity of gastritis are not associated with iron deficiency in a group of Brazilian patients
  29. Cardiovascular Diseases
  30. Proatrial natriuretic peptide is a better predictor of 28-day mortality in septic shock patients than proendothelin-1
  31. The relationship between aminoterminal propeptide of type III procollagen and heart rate variability parameters in heart failure patients: a potential serum marker to evaluate cardiac autonomic control and sudden cardiac death
  32. Relationship of hepatic steatosis and alanine aminotransferase with coronary calcification
  33. Letters to the Editor
  34. Novel mutation at codon 110 of the human APOE gene: impact on genotyping with fluorescent hybridization probes
  35. A simple, fast and inexpensive automated technique for measurement of plasma nitrite
  36. Development of an innovative serological test for detection of antibodies to Treponema pallidum
  37. Erratum
  38. Controversies on quotient reporting to standardise laboratory results
  39. Acknowledgement
  40. Acknowledgement
Downloaded on 6.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2010.334/html
Scroll to top button